The proteome profiling services market is projected to be worth USD 16 billion by 2030, growing at a CAGR of 15%, claims Roots Analysis

 Proteome profiling is a technically complex and financially demanding field of research, as a result both pharmaceutical companies and research institutes prefer to rely on specialty service providers that claim to have the required expertise

 

Roots Analysis is pleased to announce the publication of its recent study, titled, “Proteome Profiling Services Market, 2020-2030.”

 

The report features an extensive study of the current market landscape and future opportunities associated with proteome profiling service providers. The study also features a detailed analysis of the key drivers and trends related to this evolving domain. Amongst other elements, the report includes:

 

§  A detailed review of the overall landscape of companies offering proteome profiling services, along with information on type of service provider, year of establishment, company size, location of headquarters, service(s) offered for pre-proteome profiling, service(s) offered for proteome profiling, other service(s) offered, type of product profiled and type of sample(s) used.

§  Detailed profiles of prominent proteome profiling players (shortlisted on the basis of the number of pipeline services).

§  An analysis of the partnerships that have been established in this domain, in the recent past.

§  A competitiveness analysis of proteome profiling services, featuring insightful pictorial summaries and representations.

§  An elaborate discussion on various factors contributing to the high price of proteome profiling.

§  A discussion on affiliated trends, key drivers and challenges which are likely to impact the industry’s evolution, under a comprehensive SWOT framework.

§  A detailed review of the impact of the COVID-19 pandemic on the overall proteome profiling services market.

§  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):

§  Application Area

§  Drug Discovery

§  Disease Diagnosis

§  Others

 

§  Type of Sponsor(s)

§  Contract Research Organizations

§  Pharmaceutical Companies

§  Research and Academic Institutes

 

§  Key Geographical Regions

§  North America

§  Europe

§  Asia-Pacific and the Rest of the World 

 

Key companies covered in the report

§  Biognosys

§  BGI

§  Bioproximity

§  Cell Signaling Technology

§  Creative Biolabs

§  Creative Proteomics

§  Cytomics

§  i-DNA Biotechnology

§  NMI TT Pharmaservices

§  Poochon Scientific

§  Proteomics International

§  Proteome Factory

§  Sciomics

§  tebu-bio

§  VProteomics

 

For more information please click on the following link:

https://www.rootsanalysis.com/reports/proteome-profiling-services.html

 

Other Recent Offerings

1.      Peptides and Macrocycle Drug Discovery: Services and Platforms Market, 2020 – 2030

2.     Peptide Therapeutics: Contract API Manufacturing Market, 2020 - 2030

3.     Targeted Protein Degradation Market: Focus on Therapeutics and Technology Platforms (based on Degronimids, ENDTACs, Epichaperome Inhibitors, Hydrophobic Tags, IMiDs, LYTACs, Molecular Glues, PHOTACs, PROTACs, Protein Homeostatic Modulators, SARDs, SERDs, SNIPERs, and Specific BET and DUB Inhibitors), 2020-2030

 

 

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

 

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

ben.johnson@rootsanalysis.com

Facebook - https://www.facebook.com/RootsAnalysis

LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/

Twitter - https://twitter.com/RootsAnalysis

Comments

Post a Comment

Popular posts from this blog

The microbial contract biomanufacturing market is growing at a CAGR of 8.7%, claims {Roots Analysis}

    The growing pipeline of biologics that can be produced in microbial systems, such as antibody fragments and plasmid-based therapies, is anticipated to offer lucrative opportunities to service providers serving this niche, but growing market segment     London   Roots Analysis has announced the addition of the “ Microbial Contract Biomanufacturing Market, 2020-2030 ” report to its list of offerings.   Despite mammalian cell cultures being the preferred manufacturing approach for biologics, recent advances in microbial fermentation have enabled the development of versatile biomanufacturing systems, which are both robust and cost friendly. Presently, a number of service provider companies claim to offer end-to-end solutions, ranging from product development to commercial production, for microbial biologics. Given the obvious advantages of outsourcing, drug developers are likely to continue relying on contract service providers for various...
Read more

Manufacturing Market Continuous (Small Molecules and Biologics), 2020 – 2030 by Roots Analysis

  Recent advances in the manufacturing technologies have prompted pharmaceutical companies to consider shifting from the traditional multi-step, batch manufacturing processes to faster, and relatively more efficient continuous manufacturing   Roots Analysis is pleased to announce the publication of its recent study, titled, “ Manufacturing Market Continuous (Small Molecules and Biologics), 2020 – 2030 .”   The report features an extensive study of the current market landscape and future opportunities for companies with capabilities in continuous manufacturing (both innovator companies with in-house expertise and contract manufacturers). It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes: §   A detailed assessment of the overall landscape of companies with capabilities for continuous manufacturing §   Elaborate profiles of some of the key...
Read more

A relatively larger proportion of these firms are headquartered in the US, claims Roots Analysis

  Lately, drug manufacturers have started showing evident interest in modular facilities and using modularity in design approaches owing to the amplified value of smaller production facilities, which are more efficient and flexible. The increased demand for multi-product, multi-purpose, smaller batch size facilities has also prompted equipment manufacturers to revisit their product offerings.   To order this 300+ page report, which features 120+ figures and 130+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/modular-facilities-flexible-drug-manufacturing-platforms-of-the-future/178.html   The USD xx billion (by 2030) financial opportunity within the modular facilities market has been analyzed across the following segments: ·        Type of Modular Construct  §   Hybrid Skid §   Plug-and-Play §   Skid-Mounted §   Truckable §   Others §   Type of Construc...
Read more